Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
Pro Tip from Dermatologists Combination therapy for example, a Q-switched laser paired with a prescription topical cream and daily SPF consistently produces the best results
When the SARS-CoV-2 virus enters the body, it initiates a massive inflammatory response
References Biomedicines (2022) Stable gastric pentadecapeptide BPC 157: pleiotropic beneficial activity and neurotransmitter interactions Current Pharmaceutical Design (2018) BPC 157 and standard angiogenic growth factors: gastrointestinal tract healing and angiogenesis Annals of the New York Academy of Sciences (2007) Thymosin 4: roles in development, repair, and regeneration Expert Opinion on Biological Therapy (2018) Thymosin 4: a multi-functional regenerative peptide
Whats in a Beauty Drip
doi:10.1016/0167-4838(93)90234-i